REPROCELL
@reprocell.bsky.social
Better translating discoveries into therapies. Follow for updates about products, services, and industry news.
Building scalable allogeneic cell therapies? 𝗙𝗿𝗼𝗺 𝗯𝗹𝗼𝗼𝗱 𝘁𝘆𝗽𝗲 𝘁𝗼 𝗛𝗟𝗔 𝗜/𝗜𝗜 𝗞𝗢 – 𝗰𝗼𝗺𝗽𝗮𝘁𝗶𝗯𝗶𝗹𝗶𝘁𝘆 𝗯𝘆 𝗱𝗲𝘀𝗶𝗴𝗻. REPROCELL's 𝗳𝗲𝗺𝗮𝗹𝗲 𝗛𝗟𝗔-𝗔 & 𝗛𝗟𝗔-𝗗𝗣𝗔𝟭, 𝗯𝗹𝗼𝗼𝗱 𝘁𝘆𝗽𝗲 𝟬+ 𝗵𝗼𝗺𝗼𝘇𝘆𝗴𝗼𝘂𝘀 𝗶𝗣𝗦𝗖 𝗹𝗶𝗻𝗲 (healthy 22-year-old donor) expands patient coverage and clinical flexibility.
Learn more: hubs.li/Q03_gq6Y0
Learn more: hubs.li/Q03_gq6Y0
January 19, 2026 at 1:46 PM
Building scalable allogeneic cell therapies? 𝗙𝗿𝗼𝗺 𝗯𝗹𝗼𝗼𝗱 𝘁𝘆𝗽𝗲 𝘁𝗼 𝗛𝗟𝗔 𝗜/𝗜𝗜 𝗞𝗢 – 𝗰𝗼𝗺𝗽𝗮𝘁𝗶𝗯𝗶𝗹𝗶𝘁𝘆 𝗯𝘆 𝗱𝗲𝘀𝗶𝗴𝗻. REPROCELL's 𝗳𝗲𝗺𝗮𝗹𝗲 𝗛𝗟𝗔-𝗔 & 𝗛𝗟𝗔-𝗗𝗣𝗔𝟭, 𝗯𝗹𝗼𝗼𝗱 𝘁𝘆𝗽𝗲 𝟬+ 𝗵𝗼𝗺𝗼𝘇𝘆𝗴𝗼𝘂𝘀 𝗶𝗣𝗦𝗖 𝗹𝗶𝗻𝗲 (healthy 22-year-old donor) expands patient coverage and clinical flexibility.
Learn more: hubs.li/Q03_gq6Y0
Learn more: hubs.li/Q03_gq6Y0
𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗶𝗻𝗴 𝗮𝗻 𝗮𝗹𝗹𝗼𝗴𝗲𝗻𝗲𝗶𝗰 𝗶𝗣𝗦𝗖-𝗱𝗲𝗿𝗶𝘃𝗲𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗮𝗻𝗱 𝗿𝗲𝗮𝗱𝘆 𝘁𝗼 𝘀𝗰𝗮𝗹𝗲 𝗶𝘁 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹𝗹𝘆? At REPROCELL, we offer 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆-𝗮𝗹𝗶𝗴𝗻𝗲𝗱, 𝗲𝗻𝗱-𝘁𝗼-𝗲𝗻𝗱 𝗚𝗠𝗣 𝗶𝗣𝗦𝗖 𝗠𝗖𝗕 𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀 with a unified workflow from donor to clinic, eliminating handoffs, delays, risk and complexity.
Explore our services: hubs.li/Q03ZNzSX0
Explore our services: hubs.li/Q03ZNzSX0
January 7, 2026 at 10:24 AM
𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗶𝗻𝗴 𝗮𝗻 𝗮𝗹𝗹𝗼𝗴𝗲𝗻𝗲𝗶𝗰 𝗶𝗣𝗦𝗖-𝗱𝗲𝗿𝗶𝘃𝗲𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗮𝗻𝗱 𝗿𝗲𝗮𝗱𝘆 𝘁𝗼 𝘀𝗰𝗮𝗹𝗲 𝗶𝘁 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹𝗹𝘆? At REPROCELL, we offer 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆-𝗮𝗹𝗶𝗴𝗻𝗲𝗱, 𝗲𝗻𝗱-𝘁𝗼-𝗲𝗻𝗱 𝗚𝗠𝗣 𝗶𝗣𝗦𝗖 𝗠𝗖𝗕 𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀 with a unified workflow from donor to clinic, eliminating handoffs, delays, risk and complexity.
Explore our services: hubs.li/Q03ZNzSX0
Explore our services: hubs.li/Q03ZNzSX0
What if 𝗔𝗜 could design 𝗯𝗲𝘁𝘁𝗲𝗿 𝗴𝗲𝗻𝗲 𝗲𝗱𝗶𝘁𝗼𝗿𝘀 than what evolution gave us? 𝗢𝗽𝗲𝗻𝗖𝗥𝗜𝗦𝗣𝗥-𝟭 - the first AI-designed genome editing enzyme - might be exactly that.
In our 𝗹𝗮𝘁𝗲𝘀𝘁 𝗯𝗹𝗼𝗴, we explain:
✔What OpenCRISPR-1 is & how it was created
✔Why developers should care
👉Read the 𝗯𝗹𝗼𝗴: hubs.li/Q03YjfQp0
In our 𝗹𝗮𝘁𝗲𝘀𝘁 𝗯𝗹𝗼𝗴, we explain:
✔What OpenCRISPR-1 is & how it was created
✔Why developers should care
👉Read the 𝗯𝗹𝗼𝗴: hubs.li/Q03YjfQp0
December 17, 2025 at 10:50 AM
What if 𝗔𝗜 could design 𝗯𝗲𝘁𝘁𝗲𝗿 𝗴𝗲𝗻𝗲 𝗲𝗱𝗶𝘁𝗼𝗿𝘀 than what evolution gave us? 𝗢𝗽𝗲𝗻𝗖𝗥𝗜𝗦𝗣𝗥-𝟭 - the first AI-designed genome editing enzyme - might be exactly that.
In our 𝗹𝗮𝘁𝗲𝘀𝘁 𝗯𝗹𝗼𝗴, we explain:
✔What OpenCRISPR-1 is & how it was created
✔Why developers should care
👉Read the 𝗯𝗹𝗼𝗴: hubs.li/Q03YjfQp0
In our 𝗹𝗮𝘁𝗲𝘀𝘁 𝗯𝗹𝗼𝗴, we explain:
✔What OpenCRISPR-1 is & how it was created
✔Why developers should care
👉Read the 𝗯𝗹𝗼𝗴: hubs.li/Q03YjfQp0
REPROCELL isn’t just another iPSC vendor. We’re an 𝗲𝗻𝗱-𝘁𝗼-𝗲𝗻𝗱 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗶𝗣𝗦𝗖 𝗽𝗮𝗿𝘁𝗻𝗲𝗿 covering the entire journey in-house: donor sourcing, reprogramming, GMP MCB and gene-editing support for clinical programs.
𝗢𝗻𝗲 𝗽𝗮𝗿𝘁𝗻𝗲𝗿, 𝗼𝗻𝗲 𝘀𝘂𝗽𝗽𝗹𝘆 𝗰𝗵𝗮𝗶𝗻, 𝘇𝗲𝗿𝗼 𝗵𝗮𝗻𝗱𝗼𝗳𝗳𝘀.
Learn more: hubs.li/Q03WBDmb0
𝗢𝗻𝗲 𝗽𝗮𝗿𝘁𝗻𝗲𝗿, 𝗼𝗻𝗲 𝘀𝘂𝗽𝗽𝗹𝘆 𝗰𝗵𝗮𝗶𝗻, 𝘇𝗲𝗿𝗼 𝗵𝗮𝗻𝗱𝗼𝗳𝗳𝘀.
Learn more: hubs.li/Q03WBDmb0
December 3, 2025 at 10:53 AM
REPROCELL isn’t just another iPSC vendor. We’re an 𝗲𝗻𝗱-𝘁𝗼-𝗲𝗻𝗱 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗶𝗣𝗦𝗖 𝗽𝗮𝗿𝘁𝗻𝗲𝗿 covering the entire journey in-house: donor sourcing, reprogramming, GMP MCB and gene-editing support for clinical programs.
𝗢𝗻𝗲 𝗽𝗮𝗿𝘁𝗻𝗲𝗿, 𝗼𝗻𝗲 𝘀𝘂𝗽𝗽𝗹𝘆 𝗰𝗵𝗮𝗶𝗻, 𝘇𝗲𝗿𝗼 𝗵𝗮𝗻𝗱𝗼𝗳𝗳𝘀.
Learn more: hubs.li/Q03WBDmb0
𝗢𝗻𝗲 𝗽𝗮𝗿𝘁𝗻𝗲𝗿, 𝗼𝗻𝗲 𝘀𝘂𝗽𝗽𝗹𝘆 𝗰𝗵𝗮𝗶𝗻, 𝘇𝗲𝗿𝗼 𝗵𝗮𝗻𝗱𝗼𝗳𝗳𝘀.
Learn more: hubs.li/Q03WBDmb0
Curious how to scale your iPSC-based therapy from bench to clinic? Check out the images 👇 to explore how REPROCELL delivers GMP-compliant iPSC MCB manufacturing - from donor sourcing and footprint-free reprogramming to full regulatory-ready cell banks under FDA/EMA/PMDA standards.
November 28, 2025 at 10:45 AM
Curious how to scale your iPSC-based therapy from bench to clinic? Check out the images 👇 to explore how REPROCELL delivers GMP-compliant iPSC MCB manufacturing - from donor sourcing and footprint-free reprogramming to full regulatory-ready cell banks under FDA/EMA/PMDA standards.
The recording of our recent webinar - “Innovative Cell Technologies to Bioengineer Human Tissues In Vitro for Use in R&D and Modelling Human Disease” with Prof. Stefan Przyborski, is now live!
View the recording here 👉 hubs.li/Q03VW9Bz0
Explore our Alvetex® webpage: hubs.li/Q03VWjkS0
View the recording here 👉 hubs.li/Q03VW9Bz0
Explore our Alvetex® webpage: hubs.li/Q03VWjkS0
November 26, 2025 at 11:12 AM
The recording of our recent webinar - “Innovative Cell Technologies to Bioengineer Human Tissues In Vitro for Use in R&D and Modelling Human Disease” with Prof. Stefan Przyborski, is now live!
View the recording here 👉 hubs.li/Q03VW9Bz0
Explore our Alvetex® webpage: hubs.li/Q03VWjkS0
View the recording here 👉 hubs.li/Q03VW9Bz0
Explore our Alvetex® webpage: hubs.li/Q03VWjkS0
Our custom research iPSC service supports research-grade stem cell projects, spanning the full workflow from human donor sourcing to differentiated derivatives.
Find out more: hubs.li/Q03Vm6GR0
Find out more: hubs.li/Q03Vm6GR0
November 21, 2025 at 11:45 AM
Our custom research iPSC service supports research-grade stem cell projects, spanning the full workflow from human donor sourcing to differentiated derivatives.
Find out more: hubs.li/Q03Vm6GR0
Find out more: hubs.li/Q03Vm6GR0
In our latest blog, REPROCELL dives into how 𝗲𝘅𝗼𝘀𝗼𝗺𝗲𝘀 are emerging as 𝗰𝗲𝗹𝗹-𝗳𝗿𝗲𝗲 𝗮𝗹𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝘃𝗲𝘀 to conventional cell therapies.
Read more on our blog: hubs.li/Q03TXHKp0
Check out REPROCELL's iPSC-derived Exosomes: hubs.li/Q03TXJ8j0
Read more on our blog: hubs.li/Q03TXHKp0
Check out REPROCELL's iPSC-derived Exosomes: hubs.li/Q03TXJ8j0
November 19, 2025 at 11:24 AM
In our latest blog, REPROCELL dives into how 𝗲𝘅𝗼𝘀𝗼𝗺𝗲𝘀 are emerging as 𝗰𝗲𝗹𝗹-𝗳𝗿𝗲𝗲 𝗮𝗹𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝘃𝗲𝘀 to conventional cell therapies.
Read more on our blog: hubs.li/Q03TXHKp0
Check out REPROCELL's iPSC-derived Exosomes: hubs.li/Q03TXJ8j0
Read more on our blog: hubs.li/Q03TXHKp0
Check out REPROCELL's iPSC-derived Exosomes: hubs.li/Q03TXJ8j0
We’re excited to launch highly purified iPSC-derived exosomes for pre-clinical & advanced research, made at our Japan GMP facility. Derived from StemRNA™ clinical-grade iPSCs, available in liquid & lyophilized forms, ideal for anti-aging & collagen production studies.
Learn more: hubs.li/Q03TbmM50
Learn more: hubs.li/Q03TbmM50
November 14, 2025 at 10:15 AM
We’re excited to launch highly purified iPSC-derived exosomes for pre-clinical & advanced research, made at our Japan GMP facility. Derived from StemRNA™ clinical-grade iPSCs, available in liquid & lyophilized forms, ideal for anti-aging & collagen production studies.
Learn more: hubs.li/Q03TbmM50
Learn more: hubs.li/Q03TbmM50
Advancing an iPSC therapy program? We offer GMP iPSC MCB manufacturing in the EU (via Histocell) and the US (REPROCELL USA).
• EU (Histocell): hubs.li/Q03SMwJz0
• US (REPROCELL USA): hubs.li/Q03SMtVL0
Ready to discuss your project requirements? Submit an inquiry or email us: 𝗶𝗻𝗳𝗼-𝗲𝗺𝗲𝗮@𝗿𝗲𝗽𝗿𝗼𝗰𝗲𝗹𝗹.𝗰𝗼𝗺
• EU (Histocell): hubs.li/Q03SMwJz0
• US (REPROCELL USA): hubs.li/Q03SMtVL0
Ready to discuss your project requirements? Submit an inquiry or email us: 𝗶𝗻𝗳𝗼-𝗲𝗺𝗲𝗮@𝗿𝗲𝗽𝗿𝗼𝗰𝗲𝗹𝗹.𝗰𝗼𝗺
November 12, 2025 at 11:43 AM
Advancing an iPSC therapy program? We offer GMP iPSC MCB manufacturing in the EU (via Histocell) and the US (REPROCELL USA).
• EU (Histocell): hubs.li/Q03SMwJz0
• US (REPROCELL USA): hubs.li/Q03SMtVL0
Ready to discuss your project requirements? Submit an inquiry or email us: 𝗶𝗻𝗳𝗼-𝗲𝗺𝗲𝗮@𝗿𝗲𝗽𝗿𝗼𝗰𝗲𝗹𝗹.𝗰𝗼𝗺
• EU (Histocell): hubs.li/Q03SMwJz0
• US (REPROCELL USA): hubs.li/Q03SMtVL0
Ready to discuss your project requirements? Submit an inquiry or email us: 𝗶𝗻𝗳𝗼-𝗲𝗺𝗲𝗮@𝗿𝗲𝗽𝗿𝗼𝗰𝗲𝗹𝗹.𝗰𝗼𝗺
Join our webinar on 🗓️6 Nov 2025 with Prof. Stefan Przyborski: learn how Alvetex® scaffolds can help you build layered, human-relevant tissue models.
🕛 EMEA 12:00 UK / 13:00 CET
🕛 US 12:00 EST / 09:00 PST
👉Seats are filling fast, you can save your spot here: hubs.li/Q03P57jb0
🕛 EMEA 12:00 UK / 13:00 CET
🕛 US 12:00 EST / 09:00 PST
👉Seats are filling fast, you can save your spot here: hubs.li/Q03P57jb0
November 3, 2025 at 10:06 AM
Join our webinar on 🗓️6 Nov 2025 with Prof. Stefan Przyborski: learn how Alvetex® scaffolds can help you build layered, human-relevant tissue models.
🕛 EMEA 12:00 UK / 13:00 CET
🕛 US 12:00 EST / 09:00 PST
👉Seats are filling fast, you can save your spot here: hubs.li/Q03P57jb0
🕛 EMEA 12:00 UK / 13:00 CET
🕛 US 12:00 EST / 09:00 PST
👉Seats are filling fast, you can save your spot here: hubs.li/Q03P57jb0
REPROCELL is thrilled to have attended the 2025 Cell & Gene Therapy Symposium – Mid-Atlantic in Washington D.C., where researchers, clinicians and industry united to advance cell & gene therapies from discovery to patient care.
October 31, 2025 at 10:35 AM
REPROCELL is thrilled to have attended the 2025 Cell & Gene Therapy Symposium – Mid-Atlantic in Washington D.C., where researchers, clinicians and industry united to advance cell & gene therapies from discovery to patient care.
Join us on 𝟲 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 2025 for a webinar on 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗖𝗲𝗹𝗹 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 𝘁𝗼 𝗕𝗶𝗼𝗲𝗻𝗴𝗶𝗻𝗲𝗲𝗿 𝗛𝘂𝗺𝗮𝗻 𝗧𝗶𝘀𝘀𝘂𝗲𝘀 𝙄𝙣 𝙑𝙞𝙩𝙧𝙤 𝗳𝗼𝗿 𝗨𝘀𝗲 𝗶𝗻 𝗥&𝗗 𝗮𝗻𝗱 𝗠𝗼𝗱𝗲𝗹𝗹𝗶𝗻𝗴 𝗛𝘂𝗺𝗮𝗻 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 with 𝗣𝗿𝗼𝗳. 𝗦𝘁𝗲𝗳𝗮𝗻 𝗣𝗿𝘇𝘆𝗯𝗼𝗿𝘀𝗸𝗶.
🕛 EMEA Session: 12:00 UK / 13:00 CET
🕛 US Session: 12:00 EST / 9:00 PST
🔗𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 here: hubs.li/Q03Q0-hk0
🕛 EMEA Session: 12:00 UK / 13:00 CET
🕛 US Session: 12:00 EST / 9:00 PST
🔗𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 here: hubs.li/Q03Q0-hk0
October 30, 2025 at 10:18 AM
Join us on 𝟲 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 2025 for a webinar on 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗖𝗲𝗹𝗹 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 𝘁𝗼 𝗕𝗶𝗼𝗲𝗻𝗴𝗶𝗻𝗲𝗲𝗿 𝗛𝘂𝗺𝗮𝗻 𝗧𝗶𝘀𝘀𝘂𝗲𝘀 𝙄𝙣 𝙑𝙞𝙩𝙧𝙤 𝗳𝗼𝗿 𝗨𝘀𝗲 𝗶𝗻 𝗥&𝗗 𝗮𝗻𝗱 𝗠𝗼𝗱𝗲𝗹𝗹𝗶𝗻𝗴 𝗛𝘂𝗺𝗮𝗻 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 with 𝗣𝗿𝗼𝗳. 𝗦𝘁𝗲𝗳𝗮𝗻 𝗣𝗿𝘇𝘆𝗯𝗼𝗿𝘀𝗸𝗶.
🕛 EMEA Session: 12:00 UK / 13:00 CET
🕛 US Session: 12:00 EST / 9:00 PST
🔗𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 here: hubs.li/Q03Q0-hk0
🕛 EMEA Session: 12:00 UK / 13:00 CET
🕛 US Session: 12:00 EST / 9:00 PST
🔗𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 here: hubs.li/Q03Q0-hk0
We're excited to add a 23-year-old, Caucasian male (A⁺ blood type) donor line to our StemRNA™ clinical iPSC portfolio. Multiple iPSC clones from this donor are now ready for testing, the perfect foundation for advancing your cell therapy development.
Explore more: hubs.li/Q03PSDPF0
Explore more: hubs.li/Q03PSDPF0
October 24, 2025 at 9:28 AM
We're excited to add a 23-year-old, Caucasian male (A⁺ blood type) donor line to our StemRNA™ clinical iPSC portfolio. Multiple iPSC clones from this donor are now ready for testing, the perfect foundation for advancing your cell therapy development.
Explore more: hubs.li/Q03PSDPF0
Explore more: hubs.li/Q03PSDPF0
Excited to share that thanks to the MSCRF Manufacturing Assistance grant, we’re building a full-scale GMP/CDMO facility (Maryland) for large-batch hiPSC-derived & MSC therapy manufacturing, turnkey services from banking and gene-editing to differentiation & production.
Read more: hubs.li/Q03PGxWh0
Read more: hubs.li/Q03PGxWh0
October 22, 2025 at 1:49 PM
Excited to share that thanks to the MSCRF Manufacturing Assistance grant, we’re building a full-scale GMP/CDMO facility (Maryland) for large-batch hiPSC-derived & MSC therapy manufacturing, turnkey services from banking and gene-editing to differentiation & production.
Read more: hubs.li/Q03PGxWh0
Read more: hubs.li/Q03PGxWh0
We're excited to announce that REPROCELL & Histocell have jointly achieved AEMPS GMP certification for the manufacturing of 𝗶𝗣𝗦𝗖 𝗠𝗮𝘀𝘁𝗲𝗿 & 𝗪𝗼𝗿𝗸𝗶𝗻𝗴 𝗖𝗲𝗹𝗹 𝗕𝗮𝗻𝗸𝘀 using REPROCELL’s 𝗦𝘁𝗲𝗺𝗥𝗡𝗔™ 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗶𝗣𝗦𝗖𝘀, produced at Histocell’s newly certified GMP facility in Spain.
Learn more: hubs.li/Q03PgkGb0
Learn more: hubs.li/Q03PgkGb0
October 20, 2025 at 9:35 AM
We're excited to announce that REPROCELL & Histocell have jointly achieved AEMPS GMP certification for the manufacturing of 𝗶𝗣𝗦𝗖 𝗠𝗮𝘀𝘁𝗲𝗿 & 𝗪𝗼𝗿𝗸𝗶𝗻𝗴 𝗖𝗲𝗹𝗹 𝗕𝗮𝗻𝗸𝘀 using REPROCELL’s 𝗦𝘁𝗲𝗺𝗥𝗡𝗔™ 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗶𝗣𝗦𝗖𝘀, produced at Histocell’s newly certified GMP facility in Spain.
Learn more: hubs.li/Q03PgkGb0
Learn more: hubs.li/Q03PgkGb0
In our recent webinar Dr Luana Ferrara showed how Qkine’s high-purity, animal-free growth factors & cytokines address reproducibility challenges in stem cell, organoid & disease models.
Couldn’t join us live? The 𝗳𝘂𝗹𝗹 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗿𝗲𝗰𝗼𝗿𝗱𝗶𝗻𝗴 is now online, on our 𝗬𝗼𝘂𝗧𝘂𝗯𝗲 channel → hubs.ly/Q03MVw-D0
Couldn’t join us live? The 𝗳𝘂𝗹𝗹 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗿𝗲𝗰𝗼𝗿𝗱𝗶𝗻𝗴 is now online, on our 𝗬𝗼𝘂𝗧𝘂𝗯𝗲 channel → hubs.ly/Q03MVw-D0
October 17, 2025 at 10:39 AM
In our recent webinar Dr Luana Ferrara showed how Qkine’s high-purity, animal-free growth factors & cytokines address reproducibility challenges in stem cell, organoid & disease models.
Couldn’t join us live? The 𝗳𝘂𝗹𝗹 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗿𝗲𝗰𝗼𝗿𝗱𝗶𝗻𝗴 is now online, on our 𝗬𝗼𝘂𝗧𝘂𝗯𝗲 channel → hubs.ly/Q03MVw-D0
Couldn’t join us live? The 𝗳𝘂𝗹𝗹 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗿𝗲𝗰𝗼𝗿𝗱𝗶𝗻𝗴 is now online, on our 𝗬𝗼𝘂𝗧𝘂𝗯𝗲 channel → hubs.ly/Q03MVw-D0
𝗥𝗲𝗽𝗿𝗼 𝗠𝗦𝗖𝟭𝟬 now include 𝗢𝗻𝗰𝗼𝗣𝗮𝗻𝗲𝗹 𝗴𝗲𝗻𝗼𝗺𝗶𝗰 𝗽𝗿𝗼𝗳𝗶𝗹𝗶𝗻𝗴 at every stage — from donor fibroblasts → iPSCs → iMSCs. Get assurance of chromosomal integrity via G-band karyotyping + NGS-based variant screening across 400+ cancer-related genes.
Check out Repro MSC10 here: www.reprocell.com/product-cata...
Check out Repro MSC10 here: www.reprocell.com/product-cata...
October 15, 2025 at 7:07 AM
𝗥𝗲𝗽𝗿𝗼 𝗠𝗦𝗖𝟭𝟬 now include 𝗢𝗻𝗰𝗼𝗣𝗮𝗻𝗲𝗹 𝗴𝗲𝗻𝗼𝗺𝗶𝗰 𝗽𝗿𝗼𝗳𝗶𝗹𝗶𝗻𝗴 at every stage — from donor fibroblasts → iPSCs → iMSCs. Get assurance of chromosomal integrity via G-band karyotyping + NGS-based variant screening across 400+ cancer-related genes.
Check out Repro MSC10 here: www.reprocell.com/product-cata...
Check out Repro MSC10 here: www.reprocell.com/product-cata...
GMP MCB Workflow — Part 2
Who? Our GMP stem cell team in Beltsville uses a closed system to produce iPSCs/iMSCs MCBs.
What? We collect ethically consented skin biopsies, use footprint-free StemRNA™ technology, and expand to GMP MCBs.
Why? Quality, speed, and scale for GMP MCBs.
Who? Our GMP stem cell team in Beltsville uses a closed system to produce iPSCs/iMSCs MCBs.
What? We collect ethically consented skin biopsies, use footprint-free StemRNA™ technology, and expand to GMP MCBs.
Why? Quality, speed, and scale for GMP MCBs.
September 1, 2025 at 1:34 PM
GMP MCB Workflow — Part 2
Who? Our GMP stem cell team in Beltsville uses a closed system to produce iPSCs/iMSCs MCBs.
What? We collect ethically consented skin biopsies, use footprint-free StemRNA™ technology, and expand to GMP MCBs.
Why? Quality, speed, and scale for GMP MCBs.
Who? Our GMP stem cell team in Beltsville uses a closed system to produce iPSCs/iMSCs MCBs.
What? We collect ethically consented skin biopsies, use footprint-free StemRNA™ technology, and expand to GMP MCBs.
Why? Quality, speed, and scale for GMP MCBs.
Recombinant protein inconsistencies are quietly undermining reproducibility in stem cell, organoid & disease-modeling research. Want to find out more?
Join our webinar: Raising the Standard: High-Quality & Reproducible Growth Factors for Advanced Cell Systems
www.reprocell.com/resources/we...
Join our webinar: Raising the Standard: High-Quality & Reproducible Growth Factors for Advanced Cell Systems
www.reprocell.com/resources/we...
August 29, 2025 at 9:32 AM
Recombinant protein inconsistencies are quietly undermining reproducibility in stem cell, organoid & disease-modeling research. Want to find out more?
Join our webinar: Raising the Standard: High-Quality & Reproducible Growth Factors for Advanced Cell Systems
www.reprocell.com/resources/we...
Join our webinar: Raising the Standard: High-Quality & Reproducible Growth Factors for Advanced Cell Systems
www.reprocell.com/resources/we...
Meet us at the Cell & Gene Meeting on the Mesa 2025 in Phoenix, AZ (Oct 6–8 in-person, Oct 9–10 virtual). Our stem cell expert, Joey, will be there to discuss our services.
Connect:
•MESA Partnering ONE (hubs.ly/Q03FMJWJ0) / Meeting request form (hubs.ly/Q03FMJ4q0)
•𝗝𝗼𝘀𝗲𝗽𝗵.𝗥𝗼𝗴𝗲𝗿𝘀@𝗿𝗲𝗽𝗿𝗼𝗰𝗲𝗹𝗹𝘂𝘀𝗮.𝗰𝗼𝗺
Connect:
•MESA Partnering ONE (hubs.ly/Q03FMJWJ0) / Meeting request form (hubs.ly/Q03FMJ4q0)
•𝗝𝗼𝘀𝗲𝗽𝗵.𝗥𝗼𝗴𝗲𝗿𝘀@𝗿𝗲𝗽𝗿𝗼𝗰𝗲𝗹𝗹𝘂𝘀𝗮.𝗰𝗼𝗺
August 27, 2025 at 1:17 PM
Meet us at the Cell & Gene Meeting on the Mesa 2025 in Phoenix, AZ (Oct 6–8 in-person, Oct 9–10 virtual). Our stem cell expert, Joey, will be there to discuss our services.
Connect:
•MESA Partnering ONE (hubs.ly/Q03FMJWJ0) / Meeting request form (hubs.ly/Q03FMJ4q0)
•𝗝𝗼𝘀𝗲𝗽𝗵.𝗥𝗼𝗴𝗲𝗿𝘀@𝗿𝗲𝗽𝗿𝗼𝗰𝗲𝗹𝗹𝘂𝘀𝗮.𝗰𝗼𝗺
Connect:
•MESA Partnering ONE (hubs.ly/Q03FMJWJ0) / Meeting request form (hubs.ly/Q03FMJ4q0)
•𝗝𝗼𝘀𝗲𝗽𝗵.𝗥𝗼𝗴𝗲𝗿𝘀@𝗿𝗲𝗽𝗿𝗼𝗰𝗲𝗹𝗹𝘂𝘀𝗮.𝗰𝗼𝗺
𝗥𝗘𝗣𝗥𝗢𝗖𝗘𝗟𝗟'𝘀 𝗚𝗠𝗣 𝗠𝗖𝗕𝘀: 𝗪𝗵𝗼, 𝗪𝗵𝗮𝘁, 𝗪𝗵𝘆? 𝗣𝗼𝘀𝘁 𝗦𝗲𝗿𝗶𝗲𝘀 – 𝗣𝗮𝗿𝘁 𝟭
𝗪𝗵𝗼? REPROCELL’s global stem-cell team (USA & Europe).
𝗪𝗵𝗮𝘁? We deliver GMP MCBs (iPSC, iMSC, MSC), FDA/EMA/PMDA-compliant.
𝗪𝗵𝘆? Full-cycle service from donor sourcing to QC to delivery — seamless local support.
Inquire: hubs.li/Q03Dzz-Q0
𝗪𝗵𝗼? REPROCELL’s global stem-cell team (USA & Europe).
𝗪𝗵𝗮𝘁? We deliver GMP MCBs (iPSC, iMSC, MSC), FDA/EMA/PMDA-compliant.
𝗪𝗵𝘆? Full-cycle service from donor sourcing to QC to delivery — seamless local support.
Inquire: hubs.li/Q03Dzz-Q0
August 26, 2025 at 8:19 AM
𝗥𝗘𝗣𝗥𝗢𝗖𝗘𝗟𝗟'𝘀 𝗚𝗠𝗣 𝗠𝗖𝗕𝘀: 𝗪𝗵𝗼, 𝗪𝗵𝗮𝘁, 𝗪𝗵𝘆? 𝗣𝗼𝘀𝘁 𝗦𝗲𝗿𝗶𝗲𝘀 – 𝗣𝗮𝗿𝘁 𝟭
𝗪𝗵𝗼? REPROCELL’s global stem-cell team (USA & Europe).
𝗪𝗵𝗮𝘁? We deliver GMP MCBs (iPSC, iMSC, MSC), FDA/EMA/PMDA-compliant.
𝗪𝗵𝘆? Full-cycle service from donor sourcing to QC to delivery — seamless local support.
Inquire: hubs.li/Q03Dzz-Q0
𝗪𝗵𝗼? REPROCELL’s global stem-cell team (USA & Europe).
𝗪𝗵𝗮𝘁? We deliver GMP MCBs (iPSC, iMSC, MSC), FDA/EMA/PMDA-compliant.
𝗪𝗵𝘆? Full-cycle service from donor sourcing to QC to delivery — seamless local support.
Inquire: hubs.li/Q03Dzz-Q0
We are thrilled: our blog, “Why Early Genetic Variant Detection in iPSC Cultures Is Critical for Safe & Regulatory-Compliant Cell Therapies,” is now indexed on Google Scholar—boosting visibility for stem-cell researchers & cell-therapy developers.
Read more: hubs.li/Q03CVhtJ0
Read more: hubs.li/Q03CVhtJ0
August 22, 2025 at 12:54 PM
We are thrilled: our blog, “Why Early Genetic Variant Detection in iPSC Cultures Is Critical for Safe & Regulatory-Compliant Cell Therapies,” is now indexed on Google Scholar—boosting visibility for stem-cell researchers & cell-therapy developers.
Read more: hubs.li/Q03CVhtJ0
Read more: hubs.li/Q03CVhtJ0
MSCs lead regenerative medicine—1300+ clinical trials prove their anti-inflammatory, immunomodulatory & regenerative power. REPROCELL has your pipeline covered:
-𝗚𝗠𝗣 & 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵‐𝗚𝗿𝗮𝗱𝗲 𝗠𝗦𝗖𝘀, 𝗶𝗠𝗦𝗖𝘀
-𝗦𝗲𝗰𝗿𝗲𝘁𝗼𝗺𝗲 & 𝗘𝘅𝗼𝘀𝗼𝗺𝗲 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀
🌐 Find out more: hubs.li/Q03CVgWp0
📩 Contact us: info‑us@reprocell.com
-𝗚𝗠𝗣 & 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵‐𝗚𝗿𝗮𝗱𝗲 𝗠𝗦𝗖𝘀, 𝗶𝗠𝗦𝗖𝘀
-𝗦𝗲𝗰𝗿𝗲𝘁𝗼𝗺𝗲 & 𝗘𝘅𝗼𝘀𝗼𝗺𝗲 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀
🌐 Find out more: hubs.li/Q03CVgWp0
📩 Contact us: info‑us@reprocell.com
August 20, 2025 at 10:35 AM
MSCs lead regenerative medicine—1300+ clinical trials prove their anti-inflammatory, immunomodulatory & regenerative power. REPROCELL has your pipeline covered:
-𝗚𝗠𝗣 & 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵‐𝗚𝗿𝗮𝗱𝗲 𝗠𝗦𝗖𝘀, 𝗶𝗠𝗦𝗖𝘀
-𝗦𝗲𝗰𝗿𝗲𝘁𝗼𝗺𝗲 & 𝗘𝘅𝗼𝘀𝗼𝗺𝗲 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀
🌐 Find out more: hubs.li/Q03CVgWp0
📩 Contact us: info‑us@reprocell.com
-𝗚𝗠𝗣 & 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵‐𝗚𝗿𝗮𝗱𝗲 𝗠𝗦𝗖𝘀, 𝗶𝗠𝗦𝗖𝘀
-𝗦𝗲𝗰𝗿𝗲𝘁𝗼𝗺𝗲 & 𝗘𝘅𝗼𝘀𝗼𝗺𝗲 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀
🌐 Find out more: hubs.li/Q03CVgWp0
📩 Contact us: info‑us@reprocell.com
A New Bundle: StemEdit™ Hypoimmune iPSCs (HLA-Class I or I+II knockouts) plus unmodified matched StemRNA™ parental line (research/clinical-grade version).
Visit: hubs.li/Q03D70k10
Contact: 𝗶𝗻𝗳𝗼-𝘂𝘀@𝗿𝗲𝗽𝗿𝗼𝗰𝗲𝗹𝗹𝘂𝘀𝗮.𝗰𝗼𝗺
Visit: hubs.li/Q03D70k10
Contact: 𝗶𝗻𝗳𝗼-𝘂𝘀@𝗿𝗲𝗽𝗿𝗼𝗰𝗲𝗹𝗹𝘂𝘀𝗮.𝗰𝗼𝗺
August 18, 2025 at 2:13 PM
A New Bundle: StemEdit™ Hypoimmune iPSCs (HLA-Class I or I+II knockouts) plus unmodified matched StemRNA™ parental line (research/clinical-grade version).
Visit: hubs.li/Q03D70k10
Contact: 𝗶𝗻𝗳𝗼-𝘂𝘀@𝗿𝗲𝗽𝗿𝗼𝗰𝗲𝗹𝗹𝘂𝘀𝗮.𝗰𝗼𝗺
Visit: hubs.li/Q03D70k10
Contact: 𝗶𝗻𝗳𝗼-𝘂𝘀@𝗿𝗲𝗽𝗿𝗼𝗰𝗲𝗹𝗹𝘂𝘀𝗮.𝗰𝗼𝗺